Weinberg, J. B., Volkheimer, A. D., Chen, Y., Rubach, M. P., Mwaikambo, E. D., Mukemba, J., … Anstey, N. M. (2014). The role of alternatively activated (M2) monocytes in limiting NO bioavailability in falciparum malaria. Nitric Oxide, 42, 101–101. https://doi.org/10.1016/j.niox.2014.09.012

Weinberg, J Brice, Alicia D. Volkheimer, Youwei Chen, Matthew P. Rubach, Esther D. Mwaikambo, Jackson Mukemba, Salvatory Florence, Tsin W. Yeo, Donald L. Granger, and Nicholas M. Anstey. “The role of alternatively activated (M2) monocytes in limiting NO bioavailability in falciparum malaria.” Nitric Oxide 42 (November 2014): 101–101. https://doi.org/10.1016/j.niox.2014.09.012.

Weinberg JB, Volkheimer AD, Chen Y, Rubach MP, Mwaikambo ED, Mukemba J, et al. The role of alternatively activated (M2) monocytes in limiting NO bioavailability in falciparum malaria. Nitric Oxide. 2014 Nov;42:101–101.

Weinberg, J. Brice, et al. “The role of alternatively activated (M2) monocytes in limiting NO bioavailability in falciparum malaria.” Nitric Oxide, vol. 42, Elsevier BV, Nov. 2014, pp. 101–101. Crossref, doi:10.1016/j.niox.2014.09.012.

Weinberg JB, Volkheimer AD, Chen Y, Rubach MP, Mwaikambo ED, Mukemba J, Florence S, Yeo TW, Granger DL, Anstey NM. The role of alternatively activated (M2) monocytes in limiting NO bioavailability in falciparum malaria. Nitric Oxide. Elsevier BV; 2014 Nov;42:101–101.